Clinical Trial Update: ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals [Phase 3]

View source ↗

Summary

Phase 3 safety study of Medisorb Naltrexone (VIVITROL) in health care professionals for opiate dependence has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opiate Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Opiate Dependence | Phase 3 | Status: COMPLETED | Results posted: 2013-07-29